Mold-Tek Packaging Q1 FY27 Net Sales Up 24.90% to ₹300.45 Cr, PAT Grows 14.15%
Mold-Tek Packaging reported a 24.90% increase in Net Sales to ₹300.45 crore for Q1 FY27. PAT grew 14.15% to ₹25.57 crore. Sales volume rose 6.25% to 12,089 MT. EBITDA increased 19.10% to ₹56.43 crore. The company saw strong growth in Pharma Packs (+38.75%) and Food & FMCG Packs (+26.20%).
The announcement details substantial financial growth across key metrics and strategic expansion plans into new high-margin segments, which are material to investors.
The company reported significant year-on-year growth in net sales, profit, and sales volume, along with achieving historical highs in EBITDA per kg, indicating strong operational and financial performance.
Mold-Tek Packaging Limited (MTPL) announced its financial results for the first quarter ended June 30, 2026, reporting a strong performance across key financial metrics.
Net sales for Q1 FY27 increased by 24.90% to ₹300.45 crores, compared to ₹240.56 crores in the corresponding quarter of the previous year. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 19.10% to ₹56.43 crores from ₹47.38 crores in Q1 FY26. The company's Net Profit After Tax (PAT) saw a rise of 14.15%, reaching ₹25.57 crores, up from ₹22.40 crores in the same period last year. Sales volume also experienced a growth of 6.25%, with 12,089 metric tons (MT) sold compared to 11,378 MT in Q1 FY26. Profit Before Tax (PBT) increased by 13.86% to ₹34.17 crores.
The company highlighted significant growth in its Pharma Packs vertical, with a 38.75% sales volume increase, and strong performance in Food & FMCG Packs (26.20% growth) and Paints Packs (10.82% growth). The Lube Packs segment saw a dip due to supply issues related to the Iran war. The Chairman and Managing Director, Mr. J. Lakshmana Rao, noted the company's unwavering focus on operational excellence and strategic consolidation of Hyderabad units, which are translating into improved profitability. He also mentioned that EBITDA per kg reached a historical high of ₹46.68 in Q1 FY27.
Mold-Tek has consolidated five units in Hyderabad into two major units, Annaram and Sultanpur, leading to reduced overheads and improved EBITDA margins. The company plans to enter Ophthalmic-Packs and other medical devices, and is examining entry into Electronics and Semi-conductor packaging. To meet growing demand, additional molding and assembly machines were commissioned for Pharma Packaging, and eight new injection molding machines were added for the Food & FMCG segment at Sultanpur. The Food and FMCG packs production at Panipat has doubled, with a focus on the Northern India market. The company also reported substantial reductions in transportation costs and printing wastages through strategic logistics planning and process improvements. The Paint Segment outlook remains encouraging, with anticipated industry volume growth of 8%-10%. The company also secured new clients across various sectors in Q1 FY27.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.